Stock Events

Stock Events

Denali Therapeutics (DNLI) Q2 2024 Earnings

7MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-0.86

-0.14

0.58

1.3

Details

Expected EPS

-0.694924

Actual EPS

-0.68

Surprise EPS

0.01

Surprise Percent

+2.15%

Description

Denali Therapeutics (DNLI) has reported earnings of -0.68 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.